HomeVRCA • NASDAQ
add
Verrica Pharmaceuticals Inc
Previous close
$6.73
Day range
$6.26 - $8.18
Year range
$3.28 - $12.90
Market cap
116.73M USD
Avg Volume
291.40K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 14.34M | 905.39% |
Operating expense | 9.40M | -41.53% |
Net income | -274.00K | 98.80% |
Net profit margin | -1.91 | -100.15% |
Earnings per share | 0.13 | 102.65% |
EBITDA | 1.74M | 108.49% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 21.10M | -8.11% |
Total assets | 40.90M | 24.20% |
Total liabilities | 57.94M | -13.50% |
Total equity | -17.04M | — |
Shares outstanding | 9.49M | — |
Price to book | -3.74 | — |
Return on assets | 10.17% | — |
Return on capital | 20.28% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -274.00K | 98.80% |
Cash from operations | 9.68M | 213.17% |
Cash from investing | — | — |
Cash from financing | -3.98M | -903.53% |
Net change in cash | 5.70M | 163.55% |
Free cash flow | 6.66M | 789.76% |
About
Founded
2013
Headquarters
Website
Employees
71
